T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Incyte
INCY
$24.4B
| $60.7M | 0.01% |
1,050,158
-145,595
| -12% | -$9.18M |
|
627
NiSource
NI
$20.2B
| $60.7M | 0.01% |
2,458,148
-896,396
| -27% | -$24.2M |
|
628
Choice Hotels
CHH
$4.71B
| $60.6M | 0.01% |
494,822
-20,200
| -4% | -$2.54M |
|
629
Invesco Senior Loan ETF
BKLN
$6.76B
| $60.6M | 0.01% |
+2,887,800
| New | +$60.8M |
|
630
PPG Industries
PPG
$25.5B
| $60.6M | 0.01% |
466,921
-1,646
| -0.4% | -$231K |
|
631
American Water Works
AWK
$27.1B
| $60.5M | 0.01% |
488,918
-8,348
| -2% | -$1.17M |
|
632
Alamos Gold
AGI
$13.8B
| $60.2M | 0.01% |
+5,332,959
| New | +$64.2M |
|
633
Credicorp
BAP
$29.8B
| $60.2M | 0.01% |
470,042
-170,515
| -27% | -$24.8M |
|
634
Halozyme
HALO
$11.4B
| $59.9M | 0.01% |
1,567,911
-61,990
| -4% | -$2.54M |
|
635
Host Hotels & Resorts
HST
$15.6B
| $59.8M | 0.01% |
3,720,343
+417,350
| +13% | +$6.95M |
|
636
Denali Therapeutics
DNLI
$3.97B
| $59.7M | 0.01% |
2,891,950
-553,362
| -16% | -$14M |
|
637
Watts Water Technologies
WTS
$12.8B
| $59M | 0.01% |
341,652
+385
| +0.1% | +$70.4K |
|
|
RAPT
638
DELISTED
RAPT Therapeutics
RAPT
| $58.8M | 0.01% |
442,480
+6,511
| +1% | +$1.06M |
|
639
Magnolia Oil & Gas
MGY
$6.13B
| $58.2M | 0.01% |
2,540,822
-1,821,214
| -42% | -$40.7M |
|
640
Eagle Materials
EXP
$6.41B
| $58.2M | 0.01% |
349,215
+4,179
| +1% | +$759K |
|
641
Pliant Therapeutics
PLRX
$66.9M
| $58.1M | 0.01% |
3,351,487
+380,554
| +13% | +$6.6M |
|
642
Procept Biorobotics
PRCT
$1.26B
| $57.6M | 0.01% |
1,756,503
+225,163
| +15% | +$7.68M |
|
643
Occidental Petroleum
OXY
$57.7B
| $57.6M | 0.01% |
888,078
-77,110
| -8% | -$4.85M |
|
644
Iridium Communications
IRDM
$5.27B
| $57.4M | 0.01% |
1,262,834
+62,296
| +5% | +$3.23M |
|
645
Selective Insurance
SIGI
$5.59B
| $56.7M | 0.01% |
549,230
-3,798
| -0.7% | -$381K |
|
646
Merit Medical Systems
MMSI
$5.4B
| $56.4M | 0.01% |
817,163
+2,573
| +0.3% | +$185K |
|
647
Builders FirstSource
BLDR
$7.91B
| $56.3M | 0.01% |
451,950
-235,289
| -34% | -$32.5M |
|
648
Primerica
PRI
$9.62B
| $55.9M | 0.01% |
288,293
+8,594
| +3% | +$1.76M |
|
649
Live Nation Entertainment
LYV
$43.3B
| $55.9M | 0.01% |
673,356
-1,565,246
| -70% | -$136M |
|
650
Shoals Technologies Group
SHLS
$1.37B
| $55.2M | 0.01% |
3,024,160
+22,442
| +0.7% | +$499K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.